GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
B

Beigene 6160.HK · HKD

Health Care · HKEX · 🇭🇰 Hong Kong

Compare

248.20

+1.64%

Close of 9 Nov 2026, in HKD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in USD, from our data supplier.

FY2025

Revenue

$43.03bn

FY2016FY2025

Net income

$2.31bn

FY2016FY2025

Free cash flow

$7.58bn

FY2016FY2025

Shareholders' equity

$34.14bn

FY2016FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue$43.03bn$29.86bn$19.27bn$11.10bn$9.22bn$357.0m$3.36bn$1.55bn$1.87bn$8.4m
Gross profit$36.69bn$25.20bn$16.29bn$8.85bn$7.93bn−$1.22bn−$4.47bn−$3.99bn−$279.0m−$759.8m
Research and development$16.70bn$15.31bn$13.94bn$12.86bn$11.43bn$1.50bn$7.27bn$5.32bn$2.11bn$768.2m
Operating income$3.60bn−$4.45bn−$9.46bn−$14.02bn−$11.27bn−$1.92bn−$7.52bn−$5.53bn−$771.5m−$917.3m
Net income$2.31bn−$5.05bn−$6.91bn−$15.70bn−$11.42bn−$1.88bn−$7.43bn−$5.28bn−$729.6m−$934.2m
Diluted earnings per share1.54-3.66-5.11-11.64-9.25-1.59-9.42-6.84-1.23-1.81

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Total assets$64.45bn$46.40bn$45.49bn$49.99bn$67.75bn$6.47bn$12.63bn$17.63bn$8.20bn$3.18bn
Cash and short-term investments$35.92bn$20.59bn$24.88bn$35.54bn$51.91bn$5.38bn$7.72bn$14.18bn$6.56bn$2.89bn
Total liabilities$30.08bn$20.29bn$17.77bn$15.64bn$18.83bn$2.00bn$4.97bn$3.89bn$2.84bn$3.18bn
Debt$8.15bn$7.81bn$6.60bn$4.15bn$4.34bn$3.59bn$836.5m$340.4m$72.3m—
Shareholders' equity$34.14bn$26.11bn$27.72bn$34.35bn$48.92bn$4.47bn$7.67bn$13.74bn$5.36bn$2.77bn
Shares outstanding1,500m1,381m1,353m1,349m1,235m1,181m789m772m592m516m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations$9.08bn−$1.10bn−$9.07bn−$11.73bn−$10.18bn−$1.48bn−$5.88bn−$4.29bn$99.9m−$701.4m
Capital spending−$1.50bn−$4.15bn−$4.67bn−$3.68bn−$2.47bn−$264.7m−$1.24bn−$1.10bn−$460.2m−$184.2m
Free cash flow$7.58bn−$5.25bn−$13.74bn−$15.40bn−$12.64bn−$1.75bn−$7.12bn−$5.40bn−$360.3m−$885.6m

Latest quarters

By quarter end

Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024Jun 2024
Revenue$11.86bn$11.90bn$11.07bn$10.31bn$8.76bn$9.31bn$8.20bn$7.28bn
Gross profit$10.55bn$10.52bn$9.53bn$9.02bn$7.46bn$7.96bn$6.83bn$6.20bn
Operating income$1.96bn$1.47bn$1.28bn$688.7m$87.0m−$790.8m−$922.2m−$839.7m
Net income$1.78bn$528.2m$978.3m$739.1m$10.0m−$1.09bn−$1.21bn−$943.5m
Diluted earnings per share1.180.350.650.490.01-0.79-0.87-0.68
Cash from operations$1.58bn$3.33bn$3.15bn$2.06bn$345.0m$588.0m$1.48bn−$749.0m
Capital spending−$319.0m−$296.0m−$376.0m−$500.0m−$912.0m−$724.0m−$1.05bn−$861.0m
Free cash flow$1.26bn$3.04bn$2.78bn$1.56bn−$567.0m−$136.0m$429.0m−$1.61bn
Total assets$67.03bn$64.45bn$59.81bn$49.36bn$45.78bn$46.40bn$45.69bn$44.76bn
Cash and short-term investments—$35.92bn$31.63bn$21.60bn$19.72bn$20.59bn$21.17bn$20.32bn
Debt$7.54bn$8.15bn$7.59bn$7.61bn$7.38bn$8.12bn$8.38bn$8.26bn
Shareholders' equity$37.30bn$34.14bn$32.36bn$29.55bn$27.42bn$26.11bn$26.93bn$26.38bn

Financial ratios

Data as of 7 Sept 2026

FY2025FY2024FY2023FY2022FY2021FY2020FY2017FY2016FY2015
Gross margin85.3%84.4%84.5%-36.1%-38.1%-342.1%———
Operating margin8.4%-14.9%-49.1%-126.4%-122.3%-536.7%———
Net margin5.4%-16.9%-35.9%-141.5%-123.9%-526.1%———
Return on equity6.6%-19.4%-24.9%-45.7%-23.4%-42.0%———
Return on assets3.5%-10.9%-15.2%-31.4%-16.9%-29.0%———
Free cash flow yield0.4%0.1%-0.2%-0.4%-0.4%-0.4%———
Revenue growth40.4%55.0%73.7%20.4%280.8%-27.9%———
Earnings growth-144.6%-26.9%-56.0%37.5%-10.3%70.9%———
Current ratio3.41x1.80x2.32x3.55x4.76x4.61x———
Debt to equity0.24x0.31x0.26x0.13x0.10x0.14x———
Equity ratio53.0%56.3%60.9%68.7%72.2%69.1%———
Interest coverage7.68x-26.06x-276.75x———-23.97x-305.64x-46.17x
R&D as a share of sales38.8%51.3%72.3%115.9%124.1%419.2%———
Buybacks as a share of market value-8.6%-2.1%-0.3%-9.2%-4.6%-49.7%———

Growth per year

Compound annual rate

3 years5 years10 years
Revenue57.1%160.8%90.3%

Average margins

Over each period

1 year3 years5 years10 years
Gross margin84.9%84.3%83.1%70.1%
Operating margin-1.2%-23.6%-33.3%-44.0%
Net margin-3.8%-24.6%-34.3%-44.7%

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018
Price to earnings14.9-3.8-2.8-1.5-2.2-12.6-1.4-1.6
Price to sales0.80.71.02.12.866.53.05.3

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.